Olema Pharmaceuticals, Inc.
OLMA
$4.26
$0.051.19%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 434.09M | 214.76M | 239.10M | 248.98M | 261.81M |
Total Receivables | 2.12M | 687.00K | 821.00K | 664.00K | 673.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.90M | 2.36M | 2.09M | 2.27M | 2.35M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 366.00K | 188.00K | 171.00K | 177.00K | 1.68M |
Total Current Assets | 438.47M | 217.99M | 242.19M | 252.09M | 266.51M |
|
|||||
Total Current Assets | 438.47M | 217.99M | 242.19M | 252.09M | 266.51M |
Net Property, Plant & Equipment | 2.06M | 2.42M | 2.76M | 3.09M | 3.26M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 10.45M | 9.76M | 9.61M | 8.52M | 7.17M |
Total Assets | 450.98M | 230.17M | 254.56M | 263.69M | 276.95M |
|
|||||
Total Accounts Payable | 4.46M | 2.69M | 4.35M | 7.66M | 2.70M |
Total Accrued Expenses | 36.09M | 26.81M | 21.02M | 17.42M | 17.86M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.17M | 1.14M | 1.10M | 1.06M | 988.00K |
Total Finance Division Other Current Liabilities | 41.00K | 72.00K | 61.00K | 91.00K | 73.00K |
Total Other Current Liabilities | 41.00K | 72.00K | 61.00K | 91.00K | 73.00K |
Total Current Liabilities | 41.76M | 30.70M | 26.54M | 26.22M | 21.62M |
|
|||||
Total Current Liabilities | 41.76M | 30.70M | 26.54M | 26.22M | 21.62M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 257.00K | 562.00K | 859.00K | 1.15M | 1.43M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 42.02M | 31.26M | 27.39M | 27.38M | 23.05M |
|
|||||
Common Stock & APIC | 843.93M | 599.99M | 594.27M | 572.93M | 559.18M |
Retained Earnings | -435.11M | -401.54M | -366.98M | -336.60M | -305.63M |
Treasury Stock & Other | 143.00K | 464.00K | -118.00K | -10.00K | 347.00K |
Total Common Equity | 408.96M | 198.91M | 227.16M | 236.32M | 253.90M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 408.96M | 198.91M | 227.16M | 236.32M | 253.90M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 408.96M | 198.91M | 227.16M | 236.32M | 253.90M |
|